These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8615485)

  • 81. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
    Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
    Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.
    Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM
    Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
    Feola M; Biggi A; Francini A; Leonardi G; Vado A; Ribichini F; Uslenghi E
    Arch Med Res; 2006 Jan; 37(1):117-22. PubMed ID: 16314196
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Milrinone improves diastolic function in coronary artery bypass surgery as assessed by acoustic quantification and peak filling rate: a prospective randomized study.
    Axelsson B; Arbeus M; Magnuson A; Hultman J
    J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):244-9. PubMed ID: 20022262
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Trimetazidine reduces oxidative stress in cardiac surgery.
    Iskesen I; Saribulbul O; Cerrahoglu M; Var A; Nazli Y; Sirin H
    Circ J; 2006 Sep; 70(9):1169-73. PubMed ID: 16936431
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Beneficial effect of the addition of nitroglycerin to the cardioplegic solution on lipid peroxidation during coronary artery bypass surgery.
    Yavuz T; Altuntas I; Odabasi D; Delibas N; Ocal A; Ibrisim E; Kutsal A
    Int Heart J; 2005 Jan; 46(1):45-55. PubMed ID: 15858936
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy.
    Bricaud H; Brottier L; Barat JL; Combe C; Boussens B; Bonnet J
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 4():861-5. PubMed ID: 2093382
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
    Tang X; Gong J
    Cardiol Res Pract; 2022; 2022():7674366. PubMed ID: 35818572
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients.
    El-Khodary NM; Ghoneim AI; El-Tayaar AA; El-Touny EM
    Cardiovasc Drugs Ther; 2023 Oct; 37(5):955-964. PubMed ID: 35538296
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Trimetazidine Use and the Risk of Parkinsonism: A Nationwide Population-Based Study.
    Kim S; Yu YM; Kwon J; Jeong KH; Lee JS; Lee E
    Int J Environ Res Public Health; 2020 Oct; 17(19):. PubMed ID: 33020406
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Trimetazidine-Induced Parkinsonism: A Systematic Review.
    Dy AMB; Limjoco LLG; Jamora RDG
    Front Neurol; 2020; 11():44. PubMed ID: 32158422
    [No Abstract]   [Full Text] [Related]  

  • 92. The effect of trimetazidine on intrahepatic cholestasis caused by carmustine in rats.
    Demir A; Özütemiz O; Yildiz C; Yüce G; Tekeşin O; Ilter T
    Hepatol Res; 2001 May; 20(1):133-143. PubMed ID: 11282492
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.
    Dalal JJ; Mishra S
    Indian Heart J; 2017; 69(3):393-401. PubMed ID: 28648439
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting.
    Martins GF; Siqueira Filho AG; Santos JB; Assunção CR; Bottino F; Carvalho KG; Valência A
    Arq Bras Cardiol; 2011 Sep; 97(3):209-16. PubMed ID: 21808851
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting.
    Tünerir B; Colak O; Alataş O; Beşoğul Y; Kural T; Aslan R
    Ann Thorac Surg; 1999 Dec; 68(6):2173-6. PubMed ID: 10616997
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Trimetazidine and inflammatory response in coronary artery bypass grafting.
    Martins GF; Siqueira Filho AG; Santos JB; Assunção CR; Vieira FB; Valência A; Carvalho KG; Jessen B
    Arq Bras Cardiol; 2012 Aug; 99(2):688-96. PubMed ID: 22790403
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis.
    Zhang N; Lei J; Liu Q; Huang W; Xiao H; Lei H
    Cardiology; 2015; 131(2):86-96. PubMed ID: 25871315
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Myocardial protection during coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled study with trimetazidine.
    Vedrinne JM; Vedrinne C; Bompard D; Lehot JJ; Boissel JP; Champsaur G
    Anesth Analg; 1996 Apr; 82(4):712-8. PubMed ID: 8615485
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.